Armata Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) in USD from 2015 to 2018

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2018.
  • Armata Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2018 was -$328K, a 74.8% increase from 2017.
  • Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2017 was -$1.3M, a 134% decline from 2016.
  • Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2016 was -$556K, a 662% decline from 2015.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2018 -$328K +$974K +74.8% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-25
2017 -$1.3M -$746K -134% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-25
2016 -$556K -$483K -662% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-14
2015 -$73K Jan 1, 2015 Dec 31, 2015 10-K 2017-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.